SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-21-000002
Filing Date
2021-01-27
Accepted
2021-01-27 16:11:16
Documents
3
Period of Report
2021-01-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kx12721.htm 8-K 24039
2 EX-99.1 ex991-12721.htm EX-99.1 15771
3 phasebio2020logo1.jpg GRAPHIC 27705
  Complete submission text file 0001169245-21-000002.txt   79399
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 21559834
SIC: 2834 Pharmaceutical Preparations